Skip to content
Shop Our Care Store
Alzheimer's

Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says

By Cory Clark · Updated · 1 min read
senior hand holding pills with copy space
KEY POINTS FROM CNBC
  • Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows. 
  • The analysis found Alzheimer’s disease continued to progress slower in patients who took Leqembi even when they were off the treatment for an average of two years. 
  • The findings come as the Japanese drugmaker and its partner Biogen await a decision on full approval of Leqembi.

Read more at CNBC

Advertisement

The Care Pack Store

Every product in our Amazon store is something a caregiver in our community has actually used and recommends — from daily-living aids to comfort items.

Browse the store →

Cory Clark

Cory Clark is the founder of Care Pack Club and a firsthand caregiver with experience supporting both aging grandparents and parents through the challenges of elder care. After spending years navigating assisted living transitions, cognitive decline, and the emotional weight that comes with caring for the people who once cared for you, Cory created this site to share what he learned. Every article reflects a real situation, a real question, or a real decision that families face. Care Pack Club exists because Cory couldn't always find the answers he needed, and decided to document them for the next family that goes looking.

Keep reading